Market Place
Sourcing Support
All News #Library
Biotech
Acumen Pharma Raises $35.75M for Brain Delivery Molecules
16 Mar 2026 //
GLOBENEWSWIRE
Acumen Pharma Showcases Brain Delivery Tech For Antibodies
02 Dec 2025 //
GLOBENEWSWIRE
Acumen Pharma Starts Phase 2 Extension Study Of Sabirnetug
17 Nov 2025 //
GLOBENEWSWIRE
Acumen Pharma Reveals Q3 2025 Financials & Business Updates
12 Nov 2025 //
GLOBENEWSWIRE
Acumen Pharma Joins Stifel Healthcare Conference
04 Nov 2025 //
GLOBENEWSWIRE
Acumen Shows pTau217 Assay Utility in Ph2 Alzheimer’s Trial
28 Jul 2025 //
GLOBENEWSWIRE
Acumen to Present Cost, Selectivity Data at AAIC 2025
10 Jul 2025 //
GLOBENEWSWIRE
Acumen Pharmaceuticals Reports 2024 Financial Results & Highlights
27 Mar 2025 //
GLOBENEWSWIRE
Acumen Pharma Reports Ph 1 Results For Sabirnetug Subcuteneous
19 Mar 2025 //
GLOBENEWSWIRE
Acumen Pharmaceuticals Presents pTau217 Assay Data at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Acumen Presents Sabirnetug (ACU193) Data at American Academy of Neurology 2024
16 Apr 2024 //
GLOBENEWSWIRE
Acumen to Present Sabirnetug (ACU193), During Session at the AAN Meeting
21 Mar 2024 //
GLOBENEWSWIRE
Acumen to Present Deeper Insights from First-in-Human Phase 1 Study of ACU193
04 Oct 2023 //
GLOBENEWSWIRE
Acumen to Present Topline Results from First-in-Human Phase 1 Study of ACU193
13 Jun 2023 //
PRESS RELEASE
Acumen Pharmaceuticals Completes Enrollment in Phase 1 Trial of ACU193
13 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.